MPM
USNA icon

Meritage Portfolio Management’s Usana Health Sciences USNA Stock Holding History

Meritage Portfolio Management’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,523
Closed -$200K – 349
2022
Q1 		$200K Buy
2,523
+258
+11% +$23.3K 0.01% 327
2021
Q4 		$229K Buy
+2,265
New +$226K 0.01% 302

Other funds holding USNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Meritage Portfolio Management's USNA Position: Q2 2022 in Review

Meritage Portfolio Management sold out of Usana Health Sciences (USNA) in Q2 2022, closing a stake of 2,523 shares — an estimated $200K sold.

Meritage Portfolio Management first reported a position in USNA in Q4 2021 and held it in 2 quarters. The position peaked at $229K in Q4 2021. 182 funds tracked by Wall St. Rank hold USNA as of Q2 2022.

  • Meritage Portfolio Management reported no remaining Usana Health Sciences position as of Q2 2022 after selling out during the quarter.
  • Meritage Portfolio Management sold 2,523 Usana Health Sciences shares in Q2 2022, an estimated $200K.
  • Meritage Portfolio Management first reported a position in Usana Health Sciences in Q4 2021 and held it in 2 quarters.
  • Meritage Portfolio Management's Usana Health Sciences position peaked at $229K in Q4 2021.
  • 182 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2022.

Based on Meritage Portfolio Management's 13F filing for Q2 2022, filed 25 Jul 2022.